CD4 and neoplasm: Furthermore, in the grouping based on the B-cell signature gene set, we also observed differences in the number and proportion of CD4+ T cells, CD8+ T cells, and B cells between the two groups (Supplementary Fig. 3e, f), which supports the possibility that there is a gap in anti-tumor immunity with this classifying approach.